What's breaking now, across thousands of outlets.
Plus news about Luma, Inno Medicine, Schrödinger, Assembly Biosciences, Gilead, Leyden Labs, Navion, Ridge Bio, and Opus Genetics. 📊 Compass Pathways touts one-year data for psilocybin drug: The biotech’s COMP360
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- The administration of President Donald Trump filled four senior positions at the FDA on Tuesday, promoting several officials who had been serving in acting roles to permanently fill…
Bangladesh faces its worst measles outbreak, killing 1,002 children and infecting nearly 190,000 since March.
A newly discovered tick-borne virus is spreading—and the tick that carries it is already living in U.S. backyards.
Experts found the most common risk factors of dementia for American Indians were different to those for the general population.
Dolly Parton kept her cancer battle private because she did not want her fans or family to worry, sister Stella Parton revealed.
Caspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.
